Infectious Disease — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: ID, "the bug doctors." Subspecialty fellowship of Internal Medicine, reached through an IM residency and then a 2-year ID fellowship. Scope: infections of every organ system, from HIV and tuberculosis to sepsis, transplant infections, resistant organisms, and outbreaks. Organ system: none and all of them, because ID is organized around the pathogen and the host response rather than a single organ.

The 30-second version

Infectious Disease is the intellectual-detective and social-medicine corner of internal medicine, the specialty other doctors call when a fever has no source, an infection won't clear, an organism is bizarre, or an antibiotic regimen is a puzzle. ID physicians reason through undifferentiated infections, run HIV and outpatient-antibiotic clinics, steward a hospital's entire antibiotic supply, investigate outbreaks, and care for the underserved as a matter of the field's core identity rather than a side interest: people with HIV, TB, hepatitis, injection-related infections, refugees, the incarcerated, the uninsured. The work is almost purely cognitive: thinking, chart review, exam, literature, and communication, with very few procedures. That defines both its greatest strength (a humane, controllable, deeply intellectual career you can practice for decades) and its defining, honest catch: it is one of the lowest-paid specialties in all of medicine, and can pay less than the general internal medicine you trained an extra two years beyond.

Quick dashboard (details and sources below)


Training after med school	IM residency (3) + ID fellowship (2) = 5 yrs (+1 optional transplant ID / HIV / research year)
Total from college start	~13 years (4 undergrad + 4 med school + 3 IM + 2 ID); ~14 with the optional year
How you enter	Two-step: match IM from med school → then match ID as an IM fellowship (NRMP Medicine Subspecialties / fall Match)
Competitiveness (as an IM fellowship)	Low — among the least competitive; chronically UNDERFILLS (60.9% filled, 2025 Match) ⟳
Typical full-time pay	~$280,000–$325,000 total comp ⟳
Pay range (structure)	p10 ~$220k · median ~$260k–$282k · p90 ~$310k–$430k (survey-dependent) ⟳
The pay paradox	Ranks bottom 3–4 of all specialties and can earn less than general IM despite 2 extra years ⟳
Lifestyle	Cognitive/consultative; mostly daytime; benign (often from-home) call — one of ID's real selling points
Burnout	Two instruments disagree sharply. AMA 2025 puts ID at 23.3%, the lowest specialty it names, against a 41.9% all-physician average; Medscape's 2022 ID report put it at ~51% ⟳
% women	~52% of adult ID trainees (majority women); practicing workforce lags (~36% IDSA membership) ⟳
DO / IMG accessibility	Very open — one of the most IMG-heavy IM subspecialties (~39% of fellows IMG); DO-reachable ⟳

What they actually do

Infectious Disease physicians are the hospital's diagnostic consultants for infection. They are the doctors other doctors call when a case is a puzzle: an undifferentiated fever, an infection that isn't responding, a weird organism, a patient on a complex or failing antimicrobial regimen. The core skill is clinical reasoning applied to the host-pathogen relationship: integrating the exam, the microbiology, the imaging, the immune status of the patient, and the pharmacology of the drugs into a diagnosis and a treatment plan. ID physicians manage inpatient consults, run outpatient panels (HIV clinics, OPAT or outpatient parenteral antimicrobial therapy, travel medicine, general ID), lead antimicrobial stewardship (governing how an entire hospital uses antibiotics), and run hospital epidemiology / infection prevention (outbreak investigation and infection control at the institutional level).

The work is cognitive and consultative rather than hands-on and procedural, which is exactly why the field is intellectually beloved and financially penalized (see Compensation). ID also carries a distinctive social-medicine mission: caring for marginalized and underserved populations (HIV, hepatitis, TB, injection-related infection, immigrants, the incarcerated) is central to the specialty's identity, and public-health, global-health, and outbreak work are natural extensions of it.

Representative activities (note how few are procedures): inpatient infection consults · antimicrobial selection and de-escalation · interpreting cultures, sensitivities, and molecular diagnostics · HIV longitudinal care · OPAT clinic management · antimicrobial stewardship program leadership · hospital epidemiology / infection prevention · outbreak investigation · travel and pre-transplant infection consultation · tele-ID for hospitals with no local specialist.

A week in the life: Much of ID runs on alternating blocks: a consult-service week (rounding on a full inpatient list, fielding pages about positive blood cultures and antibiotic choices, teaching) alternating with clinic and administrative weeks (HIV/OPAT panels, stewardship rounds, infection-control work). It's busy but mostly daytime and cognitive; there's little of the middle-of-the-night procedural emergency work that defines cardiology, GI, or critical care. Call exists, but it is typically phone and consult call, with questions you can often handle from home, rather than "come in and cath at 3am."

The training path & time to completion

This is a subspecialty, reached through Internal Medicine in two separate matches. You do not apply to ID from medical school.

MD or DO (4 yrs) → Internal Medicine residency (3 yrs) → Infectious Disease fellowship (2 yrs) → optional +1 advanced year. You become a practicing ID physician 5 years after medical school (6 with an optional year).¹

Two-step entry: first match into an ACGME Internal Medicine residency straight from med school; then, during residency, apply through the NRMP Medicine and Pediatric Specialties Match (held in the fall) for an ID fellowship. You must be ABIM Internal Medicine board-eligible/certified to sit for ID boards.¹
Fellowship length: ID is one of the shortest IM subspecialty fellowships at 2 years (ABIM requires two years in an approved program, at least one devoted to clinical care), tied with nephrology/endocrinology/rheumatology, versus 3 years for the high-earning fellowships (cardiology, GI, heme/onc).¹
Optional +1: many academic-track fellows add a third research year (T32) or advanced training in transplant ID, HIV, or antimicrobial stewardship, none of it required to practice.¹
Board: American Board of Internal Medicine (ABIM), Certification in Infectious Disease; ABIM Internal Medicine certification is a prerequisite.¹
Total from the start of college: ~13 years (4 undergrad + 4 med school + 3 IM + 2 ID); ~14 with the extra year.

How competitive is it? (as an IM fellowship — the story you need to know)

ID is one of the clearest "hidden context" stories in medicine, and the direction is the opposite of what its intellectual prestige would suggest: ID is among the least competitive IM subspecialties and chronically underfills. For an FLI, IMG, or DO applicant, that makes it one of the most reachable subspecialties in all of internal medicine, while also being a real signal about the economics you'd be entering (see Compensation).

ID is matched through the NRMP Medicine and Pediatric Specialties Match (fall), separately from the med-school Match. The most recent cycle:²

2025 Match (Appointment Year 2026): only 272 of 447 positions filled, a 60.9% fill rate, meaning 175 slots (39.1%) went unfilled.² ⟳
A majority of programs don't fill: 101 of 184 participating programs (54.9%) left at least one slot empty.² ⟳
It's effectively a buyer's market for applicants: 319 applicants ranked ID and 272 matched, about 85%, against 447 positions on offer — roughly 0.7 applicants per position, so nearly everyone who wants ID and ranks broadly gets in.² ⟳
The trend is downward: ID's fill rate peaked at 87.7% in 2020 and fell to 60.9% in 2025, a 9.3-point drop in the last cycle alone. Applicant volume has slid from ~404 (2021) to ~319 (2026 start).²³ ⟳
Among IM fellowships, only Geriatrics (38.9%) and Advanced Heart Failure & Transplant Cardiology (59.8%) fill worse. ID sits near the very bottom, far below cardiology (100%), GI (99.5%), and heme/onc (99.5%), which fill essentially completely.² ⟳

The honest read: ID is genuinely reachable, arguably one of the most accessible respected IM subspecialties there is, but the same underfill that opens the door is the workforce crisis the field is loudly worried about, and it is driven largely by the pay paradox below.

Compensation — the robust version (and the ID pay paradox)

This is the section that matters most for ID, and the one no premed should skim. Infectious Disease is consistently one of the lowest-paid specialties in all of medicine, and, most strikingly, it frequently pays less than general Internal Medicine, the very field ID physicians train an extra two years beyond. This is the well-documented "ID pay paradox": physicians are effectively financially penalized for their additional fellowship training.⁴⁵

The paradox, in same-report comparisons (the cleanest way to see it):

Source (year)	Infectious Disease	General Internal Medicine	Paradox?
Doximity 2025 (2024 data)	$320,730	$326,116	Yes — IM out-earns ID by ~$5,400
Medscape 2026	$282,000 (27th of 29)	$307,000 (23rd of 29)	Yes — IM out-earns ID by ~$25,000

Both of the two most-cited industry surveys show general internists, who never did a fellowship, out-earning ID subspecialists.⁴⁵ Peer-reviewed analysis puts the gap even more starkly: ID-trained physicians earn roughly $40,000–$80,000 less than peers in other IM divisions at comparable career stages, and new ID grads can earn less than hospitalists who stopped at residency.⁶

National number. Estimates vary by methodology (self-reported survey vs. employer benchmark vs. government wage data), clustering in the low-$300Ks for total comp. The two most defensible anchors: Doximity 2025 $320,730 and Medscape 2026 $282,000. Base-only and wage sources sit lower because they exclude bonus, productivity and benefits: Payscale's base is ~$234,000, and BLS has no infectious-disease occupation at all, so its nearest rows are General Internal Medicine Physicians at $256,560 and the residual Physicians, All Other at $265,930, both May 2025 wages.⁴⁵⁷⁸⁹ ⟳ SalaryDr's ~$360k is an outlier from a self-selected panel of 73.⁹ A defensible "typical full-time" figure for 2025–26 is ~$280,000–$325,000 total compensation. ⟳

The spread (structure). RVUDoc (Medscape-2024 basis): p10 ~$220,000 · median ~$260,000 · p90 ~$310,000. SalaryDr's self-reported, high-skewing sample runs wider: p10 ~$275k · median ~$360k · p90 ~$429k (small sample, so treat it as an upper-bound view).⁷⁹ Base salaries are commonly $230k–$300k, with a median bonus around $65k where bonuses exist.⁹ ⟳

Starting vs. experienced. A clear upward slope that plateaus late. SalaryDr (self-reported): 0–2 yr ~$265k → 11–15 yr ~$390k (peak) → 16+ yr ~$381k. Payscale puts entry-level (<1 yr) total comp near $189k. The ceiling is low relative to the extra training, which is the whole point of the paradox.⁹⁸ ⟳

Geography. Typical physician-pay pattern, where lower-cost, higher-demand regions pay more than saturated coastal metros (RVUDoc, modeled/directional): South ~$286k (highest) · Midwest ~$281k · West ~$265k · Northeast ~$252k (lowest).⁷ Rural/underserved markets more often pay via recruitment incentives and loan repayment than via a benchmarked median, because ID is so concentrated in cities that many rural counties have no ID physician at all (see below).⁷ ⟳

Academic vs. private: the paradox appears even inside academia. ID is an unusually academic specialty (universities, VA, public health, HIV clinics), which structurally pulls average pay down. Per 2022 MGMA academic data, academic ID specialists earn less than academic general internists despite the extra fellowship, physicians "financially penalized for their additional years of training." Private/hospital-employed ID pays more than pure academic ID but still lands low among all specialties.¹⁰ No precise academic-versus-private dollar gap is available, because the full MGMA and AAMC ID tables are paywalled. ⟳

Why it happens (structural, not incidental). ID is an almost purely cognitive and consultative (E&M) specialty of inpatient consults, HIV and OPAT clinics, and stewardship, that performs few billable procedures and generates little ancillary/facility revenue (no cath lab, scope suite, imaging, or infusion ownership). Median productivity is ~4,500 wRVUs/year, low relative to procedural fields. In a fee-for-service/wRVU world that rewards procedures and volume, ID's high-value cognitive work is systematically under-reimbursed, and the field is often described as "the specialty that fee-for-service medicine punishes" because it generates value through better diagnoses, shorter stays, fewer unnecessary antibiotics, and lower mortality, none of which bills well.⁴⁷¹¹

And it's low pay for more hours. IDSA's compensation initiative (MD Ranger benchmarks) found most full-time ID physicians work >2,300 hours a year against the standard 2,000-hour FTE, "as much as 30% more than their non-ID peers." Income levers within the field are mostly administrative stipends: antimicrobial stewardship and hospital epidemiology directorships, plus quality incentives (whose effect shrinks after ~21 years).¹¹ ⟳

COVID did not fix it. Despite ID physicians being the public face of the pandemic, the specialty remains at the bottom of the 2025–26 compensation tables, the acknowledged engine of the ongoing fellowship underfill. Pediatric ID is even lower (~$248,322, Doximity 2025, among the three lowest specialties overall). IDSA is now actively promoting federal loan repayment as an ID-specific recruitment/retention tool to offset the low pay.⁴¹²¹³

Lifestyle & the cognitive-specialty bargain

The single most-cited pro of ID: for a cognitive IM subspecialty, the lifestyle is genuinely good, and it's rarely the reason people avoid the field. The work is thinking, not procedures; most of it is daytime and clinic/consult-based; and call is relatively benign, typically phone and consult questions (a positive blood culture, an antibiotic choice) you can often handle from home, not overnight operating.¹⁴

Schedule control is moderate-to-good. Outpatient ID (HIV, OPAT, travel, general clinic) is very controllable and predictable; academic and hospital-employed roles alternate defined consult-service blocks with clinic/admin weeks.¹⁴
Unusually strong non-bedside and telehealth options. ID lends itself well to tele-ID (remote consults propping up rural hospitals with no local specialist), and to largely 9-to-5 systems roles in antimicrobial stewardship and hospital epidemiology / infection prevention. Public health, CDC, pharma, and industry are realistic exits.¹⁴
Career longevity is excellent. Because nothing depends on procedural dexterity or stamina, ID is a specialty you can practice well into later career, with abundant part-time, telehealth, stewardship, and public-health lanes to adapt into.¹⁴

Lifestyle rating: 4/5. Controllable hours, mostly daytime, benign call, and many lower-intensity lanes. The catch is not the lifestyle; the catch is the pay.

Wellbeing — the honest paradox

On the free, primary instrument, ID has the lowest measured burnout of any specialty that instrument names. The AMA's 2025 Organizational Biopsy, roughly 19,000 physicians across 38 states, puts infectious diseases at 23.3% reporting at least one symptom of burnout against a 41.9% all-physician average. It is the lowest of the six low-end specialties the AMA lists, below ophthalmology (25.8%), pathology (28.3%), nephrology (29.3%), dermatology (31.5%) and psychiatry (31.6%).¹⁵ ⟳

A second instrument reads the opposite way, and the two do not belong in one sentence. Medscape's ID-specific lifestyle report, fielded in 2022 and two editions behind the 2024 report the rest of this site uses, put ID burnout at ~51% and placed the field among the most burned out. Its all-physician baseline is 49% rather than the AMA's 41.9%, so the gap between the instruments is larger than the gap between most specialties within either one, and neither ranking can be checked against the other.¹⁵ ⟳

In that Medscape survey the named drivers were bureaucratic/administrative tasks (~60%), then work hours (~45%), lack of respect / feeling undervalued (~39%), and insufficient salary (~31%), so hours were not the leading complaint.¹⁵ The recurring wound is the gap between societal importance and institutional reward, the "COVID hero who watched the specialty keep underfilling and stay near the bottom of pay." A pronounced gender gap shows up too: female ID physicians reported markedly higher burnout (~68%) than male colleagues (~39%), with more conflict around parenthood/career balance.¹⁵ ⟳

Satisfaction with the work itself is high, though. ID physicians consistently report strong intellectual satisfaction and mission alignment. They like the clinical content a great deal; the dissatisfaction clusters around pay, administrative load, and feeling undervalued, not the medicine. (Note a separate signal to weigh honestly: Medscape has ranked ID lowest on "happiest outside of work" at ~47%, so the undervaluation theme bleeds beyond the clinic.)¹⁵¹⁶ ⟳

Who's in the field (demographics)

Women are a majority of trainees. ~52% of adult ID trainees are female (pediatric ID ~72%), at or slightly above the ~50% women share of all US residents. The practicing workforce lags the pipeline, with IDSA membership at ~36% female in the 2017 diversity analysis, so the field is feminizing over time. A current national ID-fellow figure would come from ACGME's Data Resource Book, Table C.21, which counts active residents and fellows by specialty and subspecialty and sex.¹⁷³ ⟳
IMG: heavily IMG-dependent. ID is one of the most IMG-heavy IM subspecialties; roughly 39% of ID fellows are IMGs (well above the ~22% IMG share of all ACGME subspecialty fellows and the ~25% IMG share of the overall physician workforce). At one large program, 64% of fellows were IMGs and ~59% held J-1/H-1B visas. IDSA maintains dedicated IMG-pathway resources and advocates for IMG immigration pathways, reflecting how essential IMGs are to filling the field. No single primary national table carries a current % IMG among ID fellows.¹⁸¹⁹ ⟳
DO. No ID-specific national DO percentage is published. For context, DOs were ~19.2% of all ACGME residents/fellows in 2023–24; ID's chronic underfill makes it structurally reachable for DO applicants.²⁰ ⟳
URiM. Underrepresented relative to the population: adult ID trainees (2016 ACGME) were ~7% African American, ~12% Latino/Hispanic; society-membership shares were lower still (IDSA ~3% Black, ~6% Hispanic).¹⁷ ⟳

Culture, personality & the online stereotypes

Who gravitates here: intellectual "detectives" who genuinely love microbiology, immunology, and pharmacology and enjoy being the person called when no one else can figure it out; mission-driven, socially-minded physicians pulled toward global health, public health, HIV care, and the underserved; people comfortable being the least procedural, most cognitive IM subspecialist, those who'd rather reason through a case than do a procedure; and a large, welcoming international-medical-graduate community. As always, plenty of people in the field do not fit any single mold.²¹

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

"The smartest and most altruistic doctors." Flattering, but it feeds an unfair corollary that ID docs should be content with the prestige of intellect instead of pay.
"You do a fellowship to earn less, which is economically irrational." Rooted in real data (see Compensation), but wielded dismissively it erases people who choose ID clear-eyed.
"The diagnosticians, the House M.D. of the hospital." Mostly earned, with ID as the puzzle-solvers.
"COVID heroes who still got a pay cut." Captures a real grievance: public praise during the pandemic didn't translate into compensation or workforce fixes.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, the dominant thread by far is the compensation and undervaluation debate, with residents repeatedly running the same math (two extra fellowship years to earn the same as, or less than, a hospitalist), discussed with a mix of resignation and anger. Many who love ID say they'd do it again only if the numbers work for their situation: manageable debt, dual income, or valuing mission and lifestyle over max earnings. Practicing ID docs counter that the day-to-day work is the most intellectually rewarding in medicine and the lifestyle is good, while admitting the field can't recruit on passion alone forever. Running underneath it all: frustration that ID is "the specialty fee-for-service medicine punishes," and worry about the yearly fellowship underfill and a looming shortage.

Voices from the field. Paraphrased from public writing, with links to the originals:

Talia H. Swartz, MD, PhD & Judith A. Aberg, MD (Mount Sinai), in Clinical Infectious Diseases (2023), argue ID's compensation crisis is an existential threat, since ID physicians earn roughly $40k–$80k less than peers in other IM divisions at comparable stages and new grads can earn less than hospitalists, with downstream harm to recruitment, research, diversity, and care for the underserved.⁶
An ID fellow writing in Doximity's Op-Med ("The Infectious Disease Physician Is an Endangered Species," 2020) frames ID specialists as a scarce, essential, undervalued resource, noting ~79.5% of US counties had zero ID physicians.²²
IDSA & PIDS (2025 Match statement) warned that more than half of ID fellowship programs didn't fill in 2025, cited reduced funding, lower reimbursement, and rising clinical complexity, and called for loan repayment for ID physicians and better immigration pathways for IMGs.¹²

Why people choose it / why people leave

Why choose it: you love the content of micro, diagnostics, pharmacology, and the puzzle (the most intellectually engaging IM subspecialty for the right brain) · deep mission fit with underserved, global, and public health work (HIV, TB, hepatitis, outbreak response) · good, controllable lifestyle for a cognitive field with benign, often from-home call · a career you can practice long and adapt · broad career flexibility (clinical, academic, stewardship, hospital epidemiology, public health/CDC, pharma, global health) · highly reachable, since ID underfills and it's one of the most accessible IM fellowships to match into.

Why leave or avoid it: the pay, consistently among the lowest-compensated specialties and, uniquely, can pay the same as or less than general IM/hospital medicine despite two extra fellowship years · high administrative/bureaucratic burden and a persistent sense of being undervalued (the leading burnout drivers) · no procedures = limited fee-for-service leverage; your value is real but hard to bill · no high-earning ceiling if income or procedural variety is what you want.

Best fit if: you're genuinely energized by microbiology and diagnostic reasoning and would find the work its own reward · you care about underserved/global/public-health and social medicine · you value lifestyle and intellectual satisfaction over income maximization and your finances can absorb that trade (manageable debt, dual income, or modest lifestyle) · you're an IMG or DO seeking a mission-aligned, reachable, respected IM subspecialty.

Not for you if: you're carrying heavy educational debt or are the primary financial support for a family and need maximum earnings · you want procedures, a high income, or a clear RVU-driven earning ceiling · you'd resent feeling underpaid/undervalued relative to your training, even while loving the work.

The FLI angle — Infectious Disease for first-gen, low-income & immigrant students

ID is one of the most accessible and mission-aligned specialties for FLI, IMG, and DO students, with one honest, load-bearing financial catch you must weigh squarely.

Where ID fits FLI realities well:

Highly reachable. Because ID chronically underfills (more than half of fellowship programs unfilled in recent cycles), it's one of the easiest IM subspecialties to match into, a major advantage for FLI, IMG, and DO applicants who may lack the pedigree, connections, or research volume to land ultra-competitive fellowships like cardiology or GI.¹²
IMG/DO-welcoming culture. ID is genuinely one of the most IMG-heavy fields (~39% of fellows), with IDSA actively advocating for IMG immigration pathways. If you're an IMG, this is a specialty where you belong and are needed.¹⁸
Mission fit. If you came into medicine to serve underserved, immigrant, global, or public-health populations, motivations many FLI students carry, ID is built around exactly that work.
Decent, humane lifestyle with real telehealth and non-bedside options.

The honest catch, named before you commit:

ID can pay less than general internal medicine or hospital medicine — despite two additional years of fellowship training. For a FLI student carrying significant loan debt, or supporting parents, siblings, or a family, this is a real, quantifiable financial decision rather than a minor footnote.

A peer-reviewed Clinical Infectious Diseases analysis and MedMoneyGuide's internal-medicine salary aggregation agree: ID-trained physicians earn roughly $40,000–$80,000 less than other IM subspecialists at comparable stages, and new ID grads can earn less than hospitalists who never did a fellowship.⁶
Run the actual numbers for your situation: two years of fellowship at a resident-level salary (~~$65–75k) instead of an attending hospitalist salary (~~$280–330k) is a six-figure opportunity cost during training, on top of a lifetime salary that may not exceed, and could trail, what you'd earn as a hospitalist who stopped at residency.
This does not mean don't do ID. It means do it with open eyes. If you love the work, your debt is manageable, and mission matters more to you than an income ceiling, ID is a wonderful, sustainable, deeply respected career. But if you are the financial anchor for your family, or your debt load is heavy, "two more years to earn the same or less" is a legitimate reason to think hard, and possibly to choose hospital medicine or a higher-paying subspecialty instead. Don't let prestige or the "smartest, most altruistic doctors" framing pressure you into a choice your finances can't absorb.
A partial middle path, with a limit you have to know before you lean on it: PSLF at nonprofit, academic and safety-net hospitals (common employers in ID) is realistic, and IDSA is actively pushing for ID-specific federal loan repayment.¹²¹³ What PSLF discharges is the federal balance. Since July 2026 the federal system stops lending at $200,000, and medical school costs more than that at almost every school, so a reader starting now graduates with a private loan sitting alongside the federal one, and no program forgives it. That private slice is the part of this decision that argues against ID rather than for it: its payment is set by the balance rather than by your income, so it does not fall when you take the lower-paying job. Loan forgiveness genuinely softens the ID math on the federal half. It does not make the pay paradox disappear, and the hospitalist comparison above survives it.

Bottom line: ID is one of the most reachable, mission-aligned, and humane-lifestyle routes in all of internal medicine, and a place where IMG and DO applicants are genuinely welcomed and needed. That upside comes bundled with the single most important honest catch in the specialty: it can pay less than the general IM you trained two extra years beyond. Weigh that against your debt, your family obligations, and your access to loan forgiveness, with clear eyes rather than prestige.

Sub-subspecialties & niches (the lanes within ID)

None beyond the ID fellowship itself are required to practice; the lifestyle and economics shift meaningfully by lane.²³

Transplant ID. Infections in immunocompromised/transplant patients; high-acuity, academic-center-based, intellectually demanding; among the more prestigious and (relatively) better-supported ID niches (~$383k self-reported).
HIV medicine. Often functions as longitudinal primary care for people living with HIV; deeply relationship-based and mission-driven; historically undercompensated but foundational to the field's identity.
Antimicrobial stewardship. Guiding appropriate antibiotic use across a hospital; systems/quality-oriented, largely daytime and administrative; a growing, protected, lower-burnout lane.
Hospital epidemiology / infection prevention. Outbreak investigation and infection control at the institutional level; analytic and administrative, near-9-to-5, with Chief Epidemiologist leadership-track potential.
Tropical / global health. International, outbreak-response, and travel-medicine work; high mission fit, variable and often lower pay, but the classic draw for the globally minded.
Non-clinical exits ID training opens (often out-earning clinical ID): pharma/biotech (medical affairs, clinical development, MSL, vaccine/antimicrobial R&D), public health/government (CDC, NIH, health departments), consulting, diagnostics/device, and health-tech.²⁴

Fun facts

ID is one of the only fields in all of medicine where doing an extra fellowship can lower your lifetime earnings versus stopping at residency, so well known it's practically the specialty's calling card.
ID physicians were the public face of COVID-19, yet the specialty has underfilled its fellowship match year after year, with more than half of programs going unfilled in recent cycles.
Roughly 4 in 5 US counties have no ID physician at all, so access is deeply concentrated in cities and academic centers.
ID is unusually well-suited to telemedicine, since much of the cognitive consult work can be done remotely, and "tele-ID" props up rural hospitals with no local specialist.
Antimicrobial stewardship and hospital epidemiology let ID docs shape an entire hospital's care from a largely daytime, systems-level role, a rare "systems-level" lane within clinical medicine.
ID leans heavily on international medical graduates (~39% of fellows), making it one of the more globally diverse physician communities in US medicine.
ID is a two-step subspecialty, so you can't choose it out of medical school; you commit to internal medicine first, then decide.

Sources

ID training path, 2-year fellowship, two-step entry, ABIM prerequisite, optional advanced year, and shortest-IM-fellowship context. ABIM ID requirement via Johns Hopkins ACGME Adult ID Fellowship — Clinical & Research Requirements (2026) (https://www.hopkinsmedicine.org/infectious-diseases/education/fellowships/acgme-adult-infectious-diseases-fellowship/clinical-and-research-requirements); ACGME Program Requirements for GME in Infectious Disease (2025) (https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/146_infectiousdisease_2025_reformatted.pdf). ↩ ↩² ↩³ ↩⁴ ↩⁵
2025 NRMP Medicine & Pediatric Specialties Match (Appointment Year 2026): ID 447 positions, 272 filled (60.9%), 175 unfilled (39.1%), 101/184 programs did not fully fill, 319 applicants ranked ID / 272 matched (~85%), fill peaked 87.7% in 2020, only Geriatrics (38.9%) filled worse; cardiology/GI/heme-onc ~100%. NRMP, Results and Data: Specialties Matching Service 2026 Appointment Year, February 2026, Table 1A (https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf). Correction, 2026-08-13: this footnote previously gave 278 applicants and 260 matched at ~93.5%, which cannot be reconciled with the 272 filled positions in the bullet above it — a filled position is a matched applicant — and overstated the match rate by about eight points. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
Applicant-volume decline (~404 in 2021 → ~319 for 2026 start) and ~50.2% women among all US residents (2025). Today's Hospitalist, "Infectious disease fellows down, female residents take majority" (2026) (https://todayshospitalist.com/infectious-disease-fellows-drop-female-residents-take-majority/); PD Postmatch trend in Rock et al., J Infect Dis (2024) (https://academic.oup.com/jid/article/229/3/630/7600273). ↩ ↩²
Doximity 2025 Physician Compensation Report (2024 data) — ID $320,730 vs general IM $326,116; the ID pay paradox and structural (E&M, low-procedure, low-ancillary) explanation; pediatric ID $248,322. Doximity 2025 (https://www.doximity.com/reports/physician-compensation-report/2025); Becker's ASC, "Physician pay in 2026: 20 stats" (https://www.beckersasc.com/asc-coding-billing-and-collections/physician-pay-in-2026-20-stats/); Med School Insiders, "Lowest Paid Medical Specialties in 2026" (Feb 5, 2026) (https://medschoolinsiders.com/pre-med/lowest-paid-medical-specialties/). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵
Medscape Physician Compensation Report 2026 — ID $282,000 (27th of 29) vs general IM $307,000 (23rd). Becker's Hospital Review, "29 physician specialties ranked by annual compensation: Medscape" (https://www.beckershospitalreview.com/compensation-issues/29-physician-specialties-ranked-by-annual-compensation-medscape/); Medscape 2025 overview (https://www.medscape.com/slideshow/2025-compensation-overview-6018103). ⟳ ↩ ↩² ↩³
ID earns ~$40k–$80k less than other IM-subspecialty peers and new grads can earn less than hospitalists; ID compensation crisis as existential threat. Swartz TH & Aberg JA, "Preserving the Future of Infectious Diseases," Clinical Infectious Diseases (2023) (https://academic.oup.com/cid/article/77/10/1387/7223213); corroborated by MedMoneyGuide, "Internal Medicine Salary" (2025/2026) (https://medmoneyguide.com/guides/internal-medicine-salary). Corrected 2026-08-17: a source of this kind stays with the host named rather than being removed. The aggregator here is corroboration rather than the basis: the $40,000–$80,000 gap is Swartz and Aberg's, published in Clinical Infectious Diseases, and the two body paragraphs that carry it already credit the peer-reviewed analysis. The one sentence that had said "market data" without saying whose now names MedMoneyGuide. ↩ ↩² ↩³
RVUDoc (Medscape-2024 basis) — median ~$260,000, p10 ~$220k / p90 ~$310k, regional medians (South $286k / Midwest $280.8k / West $265.2k / Northeast $252.2k, modeled/directional), median ~4,500 wRVUs/yr. RVUDoc, Infectious Disease (https://www.rvudoc.com/comp/infectious-disease). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵
Payscale (Apr 27, 2025) — average base ~$234,102; entry-level (<1 yr) total ~$189,294. Payscale, Infectious Disease Physician (https://www.payscale.com/research/US/Job=Physician_%2F_Doctor%2C_Infectious_Disease/Salary). On the BLS wage figure. The OEWS has no infectious-disease occupation, so there is no ID row to quote. The two codes an ID physician is counted in are General Internal Medicine Physicians, SOC 29-1216, at a median of $256,560, and the residual Physicians, All Other, SOC 29-1229, at $265,930 — both May 2025 wages. US Bureau of Labor Statistics, Occupational Employment and Wages — May 2025, Table 1 (https://www.bls.gov/news.release/archives/ocwage_05152026.htm), confirmed against the national cross-industry file (https://www.bls.gov/oes/special-requests/oesm25nat.zip). Neither is an ID figure; both are wage-only and exclude bonus, productivity and benefits, which is why they sit below this page's total-compensation band. Swept 2026-08-17: this note carried "BLS national median ~$236,350 (broad physician category)" from SalaryDr's ID career guide (https://www.salarydr.com/careers/infectious-disease), which prints "BLS National Median: $236,350" and names no SOC code. Two things were wrong. 29-1216 is General Internal Medicine Physicians specifically rather than a broad physician category, which is the same misdescription the internal medicine profile carried and corrected; and $236,350 is the May 2024 median, one release stale, the May 2025 figure being $20,210 higher. The paradox this page argues does not rest on it either way, because the paradox is measured inside single surveys that carry both an ID row and a general-IM row. SalaryDr panel size: n=73. A self-selected physician panel; the n is disclosed here because it is what the survey figures on this page rest on. ↩ ↩²
SalaryDr (Jul 2026, n=73, self-reported — small self-selected sample, skews high): median/avg total ~$360,000/$358,461; p10 $275k / p25 $340k / p75 $385k / p90 $429k; base ~$299,858 with median bonus ~$65k; starting 0–2 yr ~$265k rising to ~$390k (11–15 yr). SalaryDr, Infectious Disease (https://www.salarydr.com/specialty/infectious-disease). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵
Academic ID earns less than academic general internists (2022 MGMA academic data) — "financially penalized for their additional years of training"; academic ~$114/wRVU. Hospital Medical Director, "Physician Income By Specialty: Does Length Of Residency Determine Compensation?" (https://hospitalmedicaldirector.com/physician-income-by-specialty-does-length-of-residency-determine-compensation/). The MGMA and AAMC ID tables that would give a precise academic-versus-private gap are paywalled. ↩
IDSA compensation initiative (MD Ranger benchmarks) — most full-time ID physicians work >2,300 hrs/yr (~30% more than non-ID peers); stewardship/epidemiology admin stipends and quality incentives as income levers; "fee-for-service punishes ID" framing. IDSA ID Physician Compensation Data (https://www.idsociety.org/practice-resources/professional-development/id-physician-compensation-initiative/id-physician-compensation-data/). ↩ ↩²
2025 Match underfill (>half of programs unfilled), reduced funding/reimbursement/rising complexity, and IDSA/PIDS call for federal loan repayment and IMG immigration pathways. IDSA & PIDS Statement on 2025 ID Fellowship Match Results (Dec 3, 2025) (https://pids.org/2025/12/03/idsa-and-pids-statement-on-2025-infectious-diseases-fellowship-match-results/ ; also https://www.idsociety.org/news--publications-new/articles/2025/idsa-and-pids-statement-on-2025-infectious-diseases-fellowship-match-results/); background: Healio, "Nearly half of ID fellowship programs go unfilled" (Nov 2023) (https://www.healio.com/news/infectious-disease/20231130/nearly-half-of-id-fellowship-programs-go-unfilled-as-shortage-persists); "Infectious Diseases Specialist, At Risk of Extinction," J Infect Dis (2023) (https://doi.org/10.1093/infdis/jiad160). ↩ ↩² ↩³ ↩⁴
Pediatric ID among the three lowest-paid specialties (~$248,322, Doximity 2025); loan repayment as ID retention tool. Doximity 2025 (https://www.doximity.com/reports/physician-compensation-report/2025); IDSA/PIDS 2025 Match statement (URL above). ↩ ↩²
ID lifestyle — cognitive/consultative, mostly daytime, benign (often from-home) call, strong telehealth/stewardship/epidemiology lanes, long adaptable careers. Synthesis of ID lifestyle research (mid-2026); Medscape Infectious Disease lifestyle context (https://www.medscape.com/viewarticle/968735). ↩ ↩² ↩³ ↩⁴
Medscape — ID burnout ~51% (among most burned out despite good hours); drivers bureaucracy ~60%, hours ~45%, feeling undervalued ~39%, insufficient salary ~31%; gender gap (female ~68% vs male ~39%). Medscape, Infectious Disease Physician Lifestyle & Burnout (2022) (https://www.medscape.com/viewarticle/968735). ⟳ A second, freely readable instrument: the AMA's 2025 Organizational Biopsy (~19,000 physicians, 38 states) puts Infectious diseases at 23.3% against a 41.9% all-physician average, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. It is primary where Medscape reaches this page through relays, and its baseline sits seven points below Medscape's 49% — the two never belong in the same sentence, and a cross-specialty rank must name which survey it comes from. Corrected 2026-08-17: the Wellbeing section, the dashboard row and the figure caption all led on Medscape's ~51% and called ID "among the most burned-out specialties," with a rank clause ("behind emergency medicine, critical care, and OB/GYN") that no readable edition supports; on Medscape's own 2024 report critical care is 45% and sits in the least-burned-out column. This site prefers AMA where it publishes a row, and AMA publishes one: infectious diseases is the lowest specialty in its table. The AMA figure now leads, the Medscape figure stays as a named second instrument with its 2022 vintage on it, and the rank clause is gone. The section heading still reads "the honest paradox," which was written for the Medscape reading and is left for a values pass, because a heading rename has to move with its authored overlay. ↩ ↩² ↩³ ↩⁴ ↩⁵
ID lowest on "happiest outside of work" (~47%), given as Medscape 2024 lifestyle by way of HCN. Unverified — do not treat as confirmed. HCN does not link the table it is reporting, and nobody here has opened the Medscape report the figure comes from. It may well be right. No URL is given for it, because pointing a reader at a secondary that cannot show its own source would look like verification and would not be any. A different Medscape question, from the 2025 report, does have ID near the bottom on whether doctors in the field can be happy and well-balanced, at about 63%; that is a separate question and a separate year and should not be merged with this one. ⟳ ↩
Demographics — ~52% of adult ID trainees female (72% peds ID); IDSA membership ~36% female; URiM ~7% Black, ~12% Latino among adult ID trainees (IDSA membership ~3% Black, ~6% Hispanic), 2016 ACGME data. Bhatt & Marcelin et al., "Diversity in the US Infectious Diseases Workforce," J Infect Dis (2017) (https://academic.oup.com/jid/article/216/suppl_5/S606/4160395). ↩ ↩²
ID ~39% of fellows are IMGs (well above the ~25% workforce IMG share); IDSA IMG advocacy. Open Forum Infectious Diseases, "IMGs Navigating Career Decisions in ID" (2026) (https://academic.oup.com/ofid/article/13/4/ofag183/8540494); IDSA IMG resources (https://www.idsociety.org/education--training/training-and-curriculum/fellows-in-training-resources/international-medical-graduate/). No single primary national table reports a current % IMG among ID fellows. ↩ ↩²
Overall ACGME subspecialty fellows ~21.9% IMG (2023–24); institutional benchmark 64.1% IMG at one large program (Mayo, 2013–2022), ~59% on J-1/H-1B. ACGME 2023–24 GME statistics (https://www.acgme.org/newsroom/2024/10/acgme-releases-2023-2024-statistics-on-graduate-medical-education-programs-and-resident-physicians/); "Factors associated with ID fellowship academic success," PMC (2024) (https://pmc.ncbi.nlm.nih.gov/articles/PMC11086035/). ↩
DOs ~19.2% of all ACGME residents/fellows (2023–24); no ID-specific national DO share is published. ACGME 2023–24 GME statistics (https://www.acgme.org/newsroom/2024/10/acgme-releases-2023-2024-statistics-on-graduate-medical-education-programs-and-resident-physicians/). ↩
Who gravitates to ID / personality — intellectual detectives, mission/social-medicine orientation, least-procedural IM subspecialists, large IMG community. Synthesis of ID culture research (mid-2026); Open Forum Infect Dis (2026) IMG article (URL above). ↩
O'Shea J, "The Infectious Disease Physician Is an Endangered Species," Doximity Op-Med (2020) — ID as scarce/undervalued; ~79.5% of US counties with zero ID physicians. https://opmed.doximity.com/articles/the-infectious-disease-physician-is-an-endangered-species ↩
ID sub-subspecialty lanes (transplant ID, HIV medicine, antimicrobial stewardship, hospital epidemiology/infection prevention, tropical/global health) and their differing economics/lifestyle; niche self-reported figures (transplant ID ~$383k, HIV-focused ~$346k) from SalaryDr's small self-reported panel. SalaryDr, Infectious Disease (https://www.salarydr.com/specialty/infectious-disease); synthesis of ID culture/lifestyle research (mid-2026). SalaryDr panel size: n=73. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩
Non-clinical exits (pharma/biotech, public health/CDC/NIH, consulting, diagnostics/device, health-tech) — often out-earning clinical ID; no ID-specific salary table is published for these exits. ID compensation research (mid-2026); IDSA/PIDS 2025 Match statement (URL above). ↩

Researched with AI assistance and reviewed by hand. How this site is made